Charles Ludivico

2.3k total citations · 1 hit paper
13 papers, 1.0k citations indexed

About

Charles Ludivico is a scholar working on Rheumatology, Genetics and Hematology. According to data from OpenAlex, Charles Ludivico has authored 13 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 4 papers in Genetics and 4 papers in Hematology. Recurrent topics in Charles Ludivico's work include Rheumatoid Arthritis Research and Therapies (8 papers), Autoimmune and Inflammatory Disorders Research (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Charles Ludivico is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (8 papers), Autoimmune and Inflammatory Disorders Research (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Charles Ludivico collaborates with scholars based in United States, Australia and Germany. Charles Ludivico's co-authors include Mark C. Genovese, Marek Krogulec, Scott D. Beattie, Omid Zamani, Josef S Smolen, William L. Macias, Terence Rooney, Douglas Schlichting, Joel Kremer and Li Xie and has published in prestigious journals such as New England Journal of Medicine, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Charles Ludivico

13 papers receiving 967 citations

Hit Papers

Baricitinib in Patients with Refractory Rheumatoid Arthritis 2016 2026 2019 2022 2016 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Baricitinib in Patients with Refractory Rheumatoid Arthritis
    2016 458 citations Mark C. Genovese, Joel Kremer et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles Ludivico United States 9 741 352 268 228 167 13 1.0k
M. C. Genovese United States 10 634 0.9× 320 0.9× 228 0.9× 162 0.7× 137 0.8× 38 842
J Jäger Australia 3 1.2k 1.7× 577 1.6× 294 1.1× 255 1.1× 89 0.5× 5 1.4k
Edit Drescher United States 13 922 1.2× 463 1.3× 486 1.8× 211 0.9× 301 1.8× 35 1.3k
Joel Kremer United States 7 1.1k 1.4× 534 1.5× 464 1.7× 306 1.3× 214 1.3× 12 1.5k
Andrea Shapiro United States 6 796 1.1× 288 0.8× 296 1.1× 186 0.8× 216 1.3× 12 1.3k
Šárka Forejtová Czechia 15 1.0k 1.4× 403 1.1× 401 1.5× 195 0.9× 213 1.3× 32 1.4k
Christina Dickson United States 10 701 0.9× 276 0.8× 221 0.8× 177 0.8× 236 1.4× 13 931
B. Combe France 13 638 0.9× 247 0.7× 301 1.1× 151 0.7× 77 0.5× 22 959
Nasser Khan United States 11 703 0.9× 343 1.0× 275 1.0× 186 0.8× 255 1.5× 27 995

Countries citing papers authored by Charles Ludivico

Since Specialization
Citations

This map shows the geographic impact of Charles Ludivico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Ludivico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Ludivico more than expected).

Fields of papers citing papers by Charles Ludivico

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Ludivico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Ludivico. The network helps show where Charles Ludivico may publish in the future.

Co-authorship network of co-authors of Charles Ludivico

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Ludivico. A scholar is included among the top collaborators of Charles Ludivico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Ludivico. Charles Ludivico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Genovese, Mark C., Joel Kremer, Omid Zamani, et al.. (2016). Baricitinib in Patients with Refractory Rheumatoid Arthritis. New England Journal of Medicine. 374(13). 1243–1252. 458 indexed citations breakdown →
2.
3.
Burmester, Gerd R, Andrea Rubbert‐Roth, Alain Cantagrel, et al.. (2015). Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA). Annals of the Rheumatic Diseases. 75(1). 68–74. 94 indexed citations
4.
Rubbert‐Roth, Andrea, Alain Cantagrel, Stephen Hall, et al.. (2014). FRI0316 The Efficacy and Safety of Subcutaneous Tocilizumab versus Intravenous Tocilizumab in Combination with Traditional DMARDS in Patients with RA at Week 97 (SUMMACTA). Annals of the Rheumatic Diseases. 73. 499–500. 1 indexed citations
5.
6.
Burmester, Gerd R, Andrea Rubbert‐Roth, Alain Cantagrel, et al.. (2013). SAT0105 Summacta: A Randomized, Double-Blind, Parallel Group Study of the Safety and Efficacy Of Tocilizumab SC Versus Tocilizumab IV, in Combination with Traditional Dmards in Patients With Moderate to Severe Ra. Annals of the Rheumatic Diseases. 72. A615–A615. 6 indexed citations
7.
Nash, Peter, Charles Ludivico, I. Delaet, et al.. (2012). Efficacy, safety and pharmacokinetics of subcutaneous abatacept in patients with rheumatoid arthritis, with or without an intravenous loading dose. Lara D. Veeken. 42. 12–12. 4 indexed citations
8.
9.
Kaine, Jeffrey, Ingrid Strusberg, Ingrid Louw, et al.. (2011). Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study). Annals of the Rheumatic Diseases. 71(1). 38–44. 63 indexed citations
10.
Schumacher, H. Ralph, Jeffrey L. Miller, Charles Ludivico, & Ralph A. Jessar. (1981). Erosive arthritis associated with apatite crystal deposition. Arthritis & Rheumatism. 24(1). 31–37. 55 indexed citations
11.
Ludivico, Charles & Allen R. Myers. (1980). Survey of synovial fluid cryoprecipitates.. Annals of the Rheumatic Diseases. 39(3). 253–259. 4 indexed citations
12.
Ludivico, Charles, et al.. (1979). Hypocomplementemic urticarial vasculitis with glomerulonephritis and pseudotumor cerebri. Arthritis & Rheumatism. 22(9). 1024–1028. 33 indexed citations
13.
Ludivico, Charles & Allen R. Myers. (1979). Survey for immune complexes in disseminated gonococcal arthritis‐dermatitis syndrome. Arthritis & Rheumatism. 22(1). 19–24. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. C. Genovese Breakdown of academic impact, for papers by J Jäger Breakdown of academic impact, for papers by Edit Drescher Breakdown of academic impact, for papers by Joel Kremer Breakdown of academic impact, for papers by Andrea Shapiro Breakdown of academic impact, for papers by Šárka Forejtová Breakdown of academic impact, for papers by Christina Dickson Breakdown of academic impact, for papers by B. Combe Breakdown of academic impact, for papers by Nasser Khan
Rankless by CCL
2026